Patents by Inventor M. Terrence Howell

M. Terrence Howell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
    Patent number: 7332185
    Abstract: A novel formulation is provided that serves to specifically inhibit the COX-2 mediated inflammation response in animals. The formulation comprises comprising an effective amount of component I selected from the group consisting of alpha acids and beta acids and an effective amount of at least one component II selected from the group consisting of alpha acids, beta acids, essential oils, fats and waxes, with the proviso that component I and II are not the same compound. The composition provides specific inhibition of cyclooxygenase-2 with little or no effect on cyclooxygenase-1.
    Type: Grant
    Filed: October 24, 2002
    Date of Patent: February 19, 2008
    Assignee: Metaproteomics, LLC
    Inventors: John G. Babish, M. Terrence Howell
  • Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
    Patent number: 7205151
    Abstract: A novel formulation is provided that serves to specifically inhibit the COX-2 mediated inflammatory response in animals. The formulation comprises an effective amount of component I selected from the group consisting of alpha acids and beta acids and an effective amount of at least one component II selected from the group consisting of alpha acids, beta acids, essential oils, fats and waxes, with the proviso that component I and II are not the same compound. The composition provides specific inhibition of cyclooxygenase-2 with little or no effect on cyclooxygenase-1.
    Type: Grant
    Filed: June 20, 2001
    Date of Patent: April 17, 2007
    Assignee: Metaproteomics, LLC
    Inventors: John G. Babish, M. Terrence Howell
  • Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
    Publication number: 20030113393
    Abstract: A novel formulation is provided that serves to specifically inhibit the COX-2 mediated inflammation response in animals. The formulation comprises comprising an effective amount of component I selected from the group consisting of alpha acids and beta acids and an effective amount of at least one component II selected from the group consisting of alpha acids, beta acids, essential oils, fats and waxes, with the proviso that component I and II are not the same compound. The composition provides specific inhibition of cyclooxygenase-2 with little or no effect on cyclooxygenase-1.
    Type: Application
    Filed: October 24, 2002
    Publication date: June 19, 2003
    Inventors: John G. Babish, M. Terrence Howell
  • Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
    Publication number: 20030008021
    Abstract: A novel formulation is provided that serves to specifically inhibit the COX-2 mediated inflammatory response in animals. The formulation comprises comprising an effective amount of component I selected from the group consisting of alpha acids and beta acids and an effective amount of at least one component II selected from the group consisting of alpha acids, beta acids, essential oils, fats and waxes, with the proviso that component I and II are not the same compound. The composition provides specific inhibition of cyclooxygenase-2 with little or no effect on cyclooxygenase-1.
    Type: Application
    Filed: June 20, 2001
    Publication date: January 9, 2003
    Applicant: ASHNI NATURACEUTICALS, INC.
    Inventors: John G. Babish, M. Terrence Howell